Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.02
+0.16 (0.64%)
Jun 4, 2026, 12:38 PM EDT - Market open
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.38 billion as of June 4, 2026. Its market cap has increased by 241.81% in one year.
Market Cap
1.38B
Enterprise Value
1.08B
1-Year Change
241.81%
Ranking
Category
Stock Price
$25.02
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.38B, an increase of 102.08%. That is a compound annual growth rate of 69.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 1.34B | -32.57% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 1.43B |
| MBX Biosciences | 1.43B |
| Inhibrx Biosciences | 1.40B |
| ArriVent BioPharma | 1.39B |
| Septerna | 1.38B |
| Damora Therapeutics | 1.37B |
| Immatics | 1.37B |
| Precigen | 1.36B |